New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
15:27 EDTSYKMariel Therapeutics to acquire Stryker's BMP-7 assets
Mariel Therapeutics announced that it has entered into a definitive agreement to acquire Stryker Corporation's Bone Morphogenetic Protein-7, or BMP-7, assets for the potential treatment of osteoarthritis, chronic kidney disease and other organ fibrosis conditions, lupus, and obesity. Under the terms of the agreement, Mariel acquired the rights to over 450 issued and pending patents, Stryker's BMP-7-related clinical and research data, and the associated biologic materials. Stryker will have a right of first negotiation for commercial rights in the area of osteoarthritis. Financial terms of the transaction were not disclosed.
News For SYK From The Last 14 Days
Check below for free stories on SYK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
15:19 EDTSYKStryker says targeting 60% of premium market in China by end of 2015
Says targeting 80% of premium market in China by 2020.
14:49 EDTSYKStryker says targeting dividend hike in line or above EPS growth
Subscribe for More Information
14:39 EDTSYKStryker backs Q3 adjusted EPS $1.12-$1.16, consensus $1.14
Subscribe for More Information
14:36 EDTSYKStryker says globalization remains a 'top priority'
Subscribe for More Information
September 15, 2014
10:27 EDTSYKStryker to host analyst meeting with a conference call hook-up available
Analyst meeting to be held in Mahwah, NJ on September 17 at 2:30 pm. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use